Evidence map›Paper›PMID 11689450›Full record

ArticleThe EMBO journal2001

Drosophila ELL is associated with actively elongating RNA polymerase II on transcriptionally active sites in vivo.

M Gerber, J Ma, K Dean, J C Eissenberg, A Shilatifard

Abstract read
In one paragraph

Article in The EMBO journal, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed.

  1. HIRA and dPCIF1 coordinately establish totipotent chromatin and control orderly ZGA inProceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. RNA polymerase II elongation control.Annual review of biochemistry · 2012
    Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

M GerberThe Edward Doisy Department of Biochemistry and Molecular Biology, St Louis University School of Medicine, 1402 South Grand Blvd, Saint Louis, MO 63104, USA.
J Ma
K Dean
J C Eissenberg
A Shilatifard

Funding

Physiological Role of MLL and ELL Proteins in LeukemiaR01CA089455 · NCI · STOWERS INSTITUTE FOR MEDICAL RESEARCH · PI SHILATIFARD, ALI · 2001 to 2015
$3.5M
MECHANISM OF EPIGENETIC REGULATION IN DROSOPHILAR55GM057005 · NIGMS · SAINT LOUIS UNIVERSITY · PI EISSENBERG, JOEL C · 1998 to 1998
–
NCI NIH HHS 1R01CA089455NCI NIH HHS R01 CA089455NIGMS NIH HHS 1R55GM057005
6 · The paper itself

Abstract

Several factors have been biochemically characterized based on their ability to increase the overall rate of transcription elongation catalyzed by the multiprotein complex RNA polymerase II (Pol II). Among these, the ELL family of elongation factors has been shown to increase the catalytic rate of transcription elongation in vitro by suppressing transient pausing. Several fundamental biological aspects of this class of elongation factors are not known. We have cloned the Drosophila homolog (dELL) in order to test whether ELL family proteins are actually associated with the elongating Pol II in vivo. Here we report that dELL is a nuclear protein, which, like its mammalian homologs, can increase the catalytic rate of transcription elongation by Pol II in vitro. Interestingly, we find that dELL co-localizes extensively with the phosphorylated, actively elongating form of Pol II at transcriptionally active sites on Drosophila polytene chromosomes. Furthermore, dELL is relocalized from a widespread distribution pattern on polytenes under normal conditions to very few transcriptionally active puff sites upon heat shock. This observation indicates a dynamic pattern of localization of dELL in cells, which is a predicted characteristic of a Pol II general elongation factor. We also demonstrate that dELL physically interacts with Pol II. Our results strongly suggest that dELL functions with elongating RNA polymerase II in vivo.

Indexed as

Neoplasm ProteinsAnimalsCell NucleusChromosomesCloning, MolecularDNA-Binding ProteinsDrosophila melanogasterDrosophila ProteinsEmbryo, NonmammalianGene Expression Regulation, DevelopmentalHeat-Shock ProteinsHeat-Shock ResponseImmunohistochemistryMacromolecular SubstancesMolecular Sequence DataMultiprotein ComplexesDNA-Binding ProteinsDrosophila ProteinsELL protein, humanHeat-Shock ProteinsMacromolecular SubstancesMultiprotein ComplexesNeoplasm ProteinsNuclear ProteinsPeptide Elongation FactorsRNA Polymerase IITranscriptional Elongation FactorsTranscription Factors

Identifiers

PMID11689450
PMCPMC125687

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.